Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


Blood Pressure Control Target in Diabetes
Condition:   Blood Pressure Control Target in Diabetes
Intervention:   Other: Treatment strategy regarding different systolic BP goals
Sponsor:   Shanghai Jiao Tong University School of Medicine
Not yet recruiting

Thu, 17 Jan 2019 12:00:00 EST


DIA_CENTRAL:T2D Treatment Pattern in Central Europe
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Empagliflozin;   Drug: Sodium Glucose Transporter 2 inhibitor;   Drug: Dipeptidyl-peptidase 4 inhibitor;   Drug: Glucagon-like peptide 1 agonist
Sponsor:   Boehringer Ingelheim
Not yet recruiting

Thu, 17 Jan 2019 12:00:00 EST


Hyaluronic Acid With Scaling & Root Planing In Chronic Periodontitis Patients With Diabetes Mellitus Type 2
Condition:   Chronic Periodontitis
Interventions:   Procedure: Periodontal treatment with Hyaluronic acid associated with SRP;   Procedure: Scaling & root planning alone
Sponsor:   Cairo University
Completed

Thu, 17 Jan 2019 12:00:00 EST


Obesity and Endogenous Oxalate Synthesis
Conditions:   Obesity;   Kidney Stone
Interventions:   Other: Normal Individuals;   Other: Calcium Oxalate Kidney Stone Formers;   Other: Type 2 Diabetes;   Other: Type 2 diabetic kidney stone formers
Sponsors:   University of Alabama at Birmingham;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

Thu, 17 Jan 2019 12:00:00 EST


Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study
Condition:   Lower Urinary Tract Symptoms
Intervention:   Other: None- Observational Study
Sponsors:   Arbor Research Collaborative for Health;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of Michigan;   Northwestern University;   Duke University;   University of Iowa;   University of Washington;   Washington University School of Medicine
Completed

Thu, 17 Jan 2019 12:00:00 EST


A Suspected Association Between Sarcoidosis and Development of Diabetes Mellitus
Conditions:   Sarcoidosis;   Diabetes Mellitus
Interventions:   Diagnostic Test: Venous blood sample;   Diagnostic Test: Ultrasound of pancreas
Sponsor:   University of Alabama at Birmingham
Recruiting

Wed, 16 Jan 2019 12:00:00 EST


Influence of a Liquid Oat Bran Product on Blood Glucose in Patients With Poorly Controlled Type 2 Diabetes
Conditions:   Diabetes Mellitus, Type 2;   Obesity;   Overweight;   Metabolic Syndrome
Interventions:   Other: active product;   Other: reference product
Sponsors:   Stoffwechselzentrum Rhein - Pfalz;   Glucanova AB
Recruiting

Wed, 16 Jan 2019 12:00:00 EST


Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect
Conditions:   Diabetes Mellitus, Type 2;   Metabolic Syndrome
Interventions:   Dietary Supplement: Intervention A;   Dietary Supplement: Intervention B;   Dietary Supplement: Intervention C;   Dietary Supplement: Intervention D
Sponsors:   German Institute of Human Nutrition;   Beneo GmbH
Recruiting

Wed, 16 Jan 2019 12:00:00 EST


Short or Long Antibiotic Regimes in Orthopaedics
Conditions:   Osteomyelitis;   Prosthetic Joint Infection;   Diabetic Foot
Interventions:   Other: Shorter Systemic Antibiotics;   Other: Standard treatment
Sponsor:   Oxford University Hospitals NHS Trust
Not yet recruiting

Wed, 16 Jan 2019 12:00:00 EST


A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients
Conditions:   Type 2 Diabetes Mellitus;   Poor Glycemic Control
Intervention:  
Sponsors:   Qilu Hospital of Shandong University;   Bayer
Not yet recruiting

Tue, 15 Jan 2019 12:00:00 EST


A Study of Adverse Events and Suspected Adverse Drug Reactions in Pacients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
Conditions:   Cerebral Stroke;   Thrombosis, Deep Vein;   Pulmonary Embolism
Intervention:  
Sponsor:   Pfizer
Not yet recruiting

Tue, 15 Jan 2019 12:00:00 EST


Can Brisk Walking Combined With Ingestion of a Lipid-lowering Drug Improve Fat Metabolism in Muscle?
Condition:   Pre Diabetes
Interventions:   Diagnostic Test: Body Composition;   Diagnostic Test: Maximal aerobic fitness test;   Diagnostic Test: Oral glucose tolerance test;   Other: Muscle biopsy;   Other: Blood samples
Sponsors:   Liverpool John Moores University;   Diabetes UK;   Aintree University Hospitals NHS Foundation Trust;   Royal Liverpool University Hospital
Not yet recruiting

Tue, 15 Jan 2019 12:00:00 EST


Continuous Glucose Monitoring in Diabetes and Prediabetes
Conditions:   Diabetes Mellitus, Type 2;   PreDiabetes;   Obesity
Intervention:   Device: DEXCOM G6 RT-CGM
Sponsors:   Nicole Ehrhardt, MD;   DexCom, Inc.
Recruiting

Tue, 15 Jan 2019 12:00:00 EST


Information, Networks and Rewards to Optimise Adherence to Diabetic Services
Condition:   Diabetes
Interventions:   Behavioral: cash rewards for the fellow up;   Behavioral: Showing retinal photos to participants;   Behavioral: SMS reminders for participants and their family;   Behavioral: Watching brief video and basic explanation for disease;   Behavioral: Having the Diabetic Club
Sponsors:   Sun Yat-sen University;   Yangxi people hospital, Yangjiang, Guangdong Province
Not yet recruiting

Tue, 15 Jan 2019 12:00:00 EST


Prognostic Predictors of Response to Hypoglycemic Therapy
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Automatic system guided treatment;   Drug: Standard treatment
Sponsor:   Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Recruiting

Tue, 15 Jan 2019 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
FDA describes unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths

Thu, 17 Jan 2019 12:56:00 -0500


FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy
FDA approved the first generic version of Sabril for treating complex partial seizures, as an adjunctive therapy in certain patients.

Wed, 16 Jan 2019 12:51:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies
FDA describes new policies to advance development of safe and effective cell and gene therapies

Tue, 15 Jan 2019 12:23:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations
FDA issues three documents that launch next phase of Pre-Cert Pilot Program to test new approaches for the review of digital health device applications.

Mon, 07 Jan 2019 12:27:00 -0500


FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk
The FDA authorized use of a new test that measures nutrients in breast milk providing healthcare professionals with tool to aid in the nutritional management of newborns.

Fri, 21 Dec 2018 14:20:00 -0500


FDA approves new treatment for adult patients with rare, life-threatening blood disease
The FDA approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

Fri, 21 Dec 2018 10:37:00 -0500


FDA approves first treatment for rare blood disease
The FDA approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients, two years of age and older.

Fri, 21 Dec 2018 10:29:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds
Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

Thu, 20 Dec 2018 16:35:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the long-term safety oversight of the Essure device following discontinuation of its U.S. sales
The FDA provides update on Essure postmarket review study as company prepares to halt sales of the device on December 31.

Thu, 20 Dec 2018 13:40:00 -0500


FDA warns about safety risks of teething necklaces, bracelets to relieve teething pain or to provide sensory stimulation
FDA alerted parents, caregivers and health care providers to the safety risks that jewelry used for relieving teething pain pose for children.

Thu, 20 Dec 2018 11:50:00 -0500
Diabetes news from the American Diabetes Association

Latest Top (5) News